Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Point-of-Care Systems | 9 | 2021 | 2955 | 1.34 | Why? |
| Bronchiolitis | 4 | 2019 | 297 | 1.34 | Why? |
| Ultrasonography | 22 | 2021 | 4409 | 1.32 | Why? |
| Tuberculosis, Pulmonary | 3 | 2020 | 1171 | 1.00 | Why? |
| Pneumorrhachis | 1 | 2021 | 15 | 0.91 | Why? |
| Tics | 1 | 2020 | 27 | 0.86 | Why? |
| Child Health | 2 | 2020 | 940 | 0.85 | Why? |
| Perfusion | 1 | 2021 | 254 | 0.83 | Why? |
| Pediatricians | 3 | 2021 | 401 | 0.80 | Why? |
| Ultrasonography, Prenatal | 2 | 2020 | 471 | 0.76 | Why? |
| Abdomen, Acute | 1 | 2021 | 179 | 0.73 | Why? |
| Stethoscopes | 1 | 2020 | 124 | 0.73 | Why? |
| Diaphragm | 2 | 2018 | 232 | 0.71 | Why? |
| Child | 39 | 2022 | 70012 | 0.71 | Why? |
| Latent Tuberculosis | 2 | 2018 | 324 | 0.67 | Why? |
| Sexism | 1 | 2021 | 278 | 0.67 | Why? |
| Neonatal Screening | 1 | 2020 | 285 | 0.66 | Why? |
| Parents | 2 | 2020 | 2758 | 0.64 | Why? |
| Child Development | 1 | 2020 | 352 | 0.63 | Why? |
| Postnatal Care | 1 | 2020 | 346 | 0.63 | Why? |
| Lung | 22 | 2021 | 31049 | 0.62 | Why? |
| Infant, Newborn, Diseases | 1 | 2020 | 394 | 0.61 | Why? |
| Pneumothorax | 2 | 2021 | 758 | 0.60 | Why? |
| Schools | 2 | 2021 | 4187 | 0.57 | Why? |
| Systemic Inflammatory Response Syndrome | 6 | 2021 | 6653 | 0.56 | Why? |
| Midazolam | 1 | 2014 | 79 | 0.52 | Why? |
| Mediastinal Emphysema | 1 | 2021 | 519 | 0.52 | Why? |
| Gynecology | 1 | 2020 | 741 | 0.48 | Why? |
| Ketamine | 1 | 2014 | 112 | 0.47 | Why? |
| Latin America | 4 | 2021 | 1721 | 0.47 | Why? |
| Infant, Newborn | 13 | 2021 | 23105 | 0.46 | Why? |
| Infant | 19 | 2021 | 30274 | 0.46 | Why? |
| Health Facilities | 1 | 2020 | 1230 | 0.46 | Why? |
| Appendicitis | 1 | 2021 | 946 | 0.45 | Why? |
| Refugees | 1 | 2021 | 809 | 0.44 | Why? |
| Tuberculosis | 4 | 2021 | 2895 | 0.44 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.43 | Why? |
| Bipolar Disorder | 1 | 2019 | 744 | 0.41 | Why? |
| Delayed Diagnosis | 1 | 2020 | 1529 | 0.41 | Why? |
| Seizures | 1 | 2019 | 1163 | 0.40 | Why? |
| Sierra Leone | 2 | 2020 | 267 | 0.40 | Why? |
| Analgesics | 1 | 2014 | 451 | 0.39 | Why? |
| Pneumonia, Viral | 28 | 2021 | 243684 | 0.39 | Why? |
| Pandemics | 35 | 2021 | 389249 | 0.38 | Why? |
| Coronavirus Infections | 27 | 2020 | 253789 | 0.37 | Why? |
| Adolescent | 20 | 2022 | 86841 | 0.37 | Why? |
| Emergency Service, Hospital | 12 | 2020 | 14232 | 0.37 | Why? |
| Transients and Migrants | 1 | 2021 | 1468 | 0.37 | Why? |
| Humans | 81 | 2022 | 930598 | 0.37 | Why? |
| Developing Countries | 2 | 2021 | 4283 | 0.36 | Why? |
| Hypnotics and Sedatives | 1 | 2014 | 624 | 0.36 | Why? |
| Pediatrics | 2 | 2021 | 2969 | 0.35 | Why? |
| Vitamin D Deficiency | 2 | 2018 | 1782 | 0.35 | Why? |
| Betacoronavirus | 25 | 2020 | 204454 | 0.35 | Why? |
| Racism | 1 | 2021 | 1462 | 0.35 | Why? |
| Child, Preschool | 17 | 2021 | 36283 | 0.35 | Why? |
| Pregnancy Complications, Infectious | 4 | 2020 | 11559 | 0.34 | Why? |
| Italy | 17 | 2021 | 38444 | 0.33 | Why? |
| Lung Diseases | 1 | 2019 | 2361 | 0.30 | Why? |
| Female | 37 | 2022 | 380317 | 0.25 | Why? |
| Health Status Disparities | 1 | 2021 | 4072 | 0.25 | Why? |
| Vitamin D | 1 | 2018 | 2904 | 0.25 | Why? |
| Prescriptions | 2 | 2021 | 258 | 0.24 | Why? |
| Attitude of Health Personnel | 1 | 2020 | 4741 | 0.24 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.24 | Why? |
| Pneumonia | 2 | 2021 | 5652 | 0.24 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.24 | Why? |
| Niger | 1 | 2021 | 116 | 0.23 | Why? |
| Pregnancy | 9 | 2020 | 23879 | 0.22 | Why? |
| Physicians | 1 | 2021 | 4214 | 0.22 | Why? |
| Child, Hospitalized | 2 | 2022 | 556 | 0.21 | Why? |
| Trichothecenes | 1 | 2019 | 13 | 0.20 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.20 | Why? |
| Male | 29 | 2021 | 367725 | 0.20 | Why? |
| Embolism, Air | 1 | 2018 | 23 | 0.19 | Why? |
| Child, Adopted | 1 | 2018 | 15 | 0.19 | Why? |
| Pediatric Emergency Medicine | 1 | 2020 | 120 | 0.19 | Why? |
| Infectious Disease Transmission, Vertical | 3 | 2020 | 5164 | 0.18 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.18 | Why? |
| Nerve Growth Factor | 1 | 2017 | 38 | 0.18 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.17 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 8811 | 0.17 | Why? |
| Social Change | 1 | 2021 | 303 | 0.17 | Why? |
| Deep Sedation | 1 | 2018 | 121 | 0.17 | Why? |
| Ultrasonography, Doppler | 1 | 2020 | 406 | 0.16 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.16 | Why? |
| Benchmarking | 1 | 2020 | 627 | 0.16 | Why? |
| Prenatal Diagnosis | 1 | 2019 | 345 | 0.16 | Why? |
| Cerebellar Diseases | 1 | 2017 | 90 | 0.16 | Why? |
| Interferon-gamma Release Tests | 1 | 2018 | 253 | 0.15 | Why? |
| Lectins | 1 | 2018 | 311 | 0.15 | Why? |
| Prospective Studies | 9 | 2022 | 43301 | 0.14 | Why? |
| Gastrointestinal Contents | 1 | 2014 | 7 | 0.14 | Why? |
| Diagnosis, Differential | 2 | 2020 | 7220 | 0.14 | Why? |
| Cerebral Cortex | 1 | 2017 | 276 | 0.14 | Why? |
| Milk, Human | 2 | 2020 | 956 | 0.14 | Why? |
| Gestational Age | 1 | 2020 | 1488 | 0.14 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.14 | Why? |
| Abortion, Spontaneous | 1 | 2020 | 776 | 0.13 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.13 | Why? |
| Catheterization, Central Venous | 1 | 2018 | 458 | 0.13 | Why? |
| Social Work | 1 | 2021 | 598 | 0.13 | Why? |
| History, 21st Century | 1 | 2021 | 1849 | 0.13 | Why? |
| Administration, Intranasal | 2 | 2017 | 1132 | 0.13 | Why? |
| Air Travel | 1 | 2020 | 585 | 0.13 | Why? |
| Intensive Care Units, Pediatric | 1 | 2020 | 1098 | 0.12 | Why? |
| Point-of-Care Testing | 3 | 2021 | 2782 | 0.12 | Why? |
| Global Health | 3 | 2021 | 13911 | 0.12 | Why? |
| Hospitals, Pediatric | 2 | 2020 | 1792 | 0.12 | Why? |
| Brain Injuries, Traumatic | 1 | 2017 | 381 | 0.12 | Why? |
| Emigrants and Immigrants | 1 | 2021 | 888 | 0.12 | Why? |
| Respiratory Insufficiency | 3 | 2021 | 7301 | 0.11 | Why? |
| Noninvasive Ventilation | 2 | 2021 | 2329 | 0.11 | Why? |
| Psychotherapy | 1 | 2019 | 747 | 0.11 | Why? |
| Hong Kong | 1 | 2020 | 3361 | 0.11 | Why? |
| Income | 1 | 2020 | 1564 | 0.11 | Why? |
| Delivery, Obstetric | 1 | 2020 | 1292 | 0.11 | Why? |
| Aftercare | 1 | 2020 | 1637 | 0.10 | Why? |
| Continuity of Patient Care | 1 | 2020 | 1574 | 0.10 | Why? |
| Environmental Exposure | 1 | 2021 | 1558 | 0.10 | Why? |
| Microbiota | 1 | 2020 | 1240 | 0.10 | Why? |
| Airway Management | 1 | 2020 | 1298 | 0.10 | Why? |
| Breast Feeding | 1 | 2020 | 1585 | 0.10 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.10 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.09 | Why? |
| Carrier State | 1 | 2020 | 2100 | 0.09 | Why? |
| Adult | 9 | 2021 | 244371 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Evidence-Based Medicine | 1 | 2021 | 3228 | 0.09 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.09 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.08 | Why? |
| Rural Population | 1 | 2020 | 2408 | 0.08 | Why? |
| Family | 1 | 2021 | 2909 | 0.08 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.08 | Why? |
| Sepsis | 2 | 2021 | 3517 | 0.08 | Why? |
| Pilot Projects | 2 | 2021 | 5182 | 0.08 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.08 | Why? |
| Health Resources | 1 | 2020 | 2592 | 0.08 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.08 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.07 | Why? |
| China | 3 | 2021 | 50654 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.07 | Why? |
| Triage | 2 | 2020 | 7151 | 0.07 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.06 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.06 | Why? |
| United States | 2 | 2021 | 46150 | 0.06 | Why? |
| Equipment Design | 1 | 2014 | 3095 | 0.06 | Why? |
| Risk Factors | 6 | 2022 | 71621 | 0.06 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.06 | Why? |
| Double-Blind Method | 1 | 2014 | 5988 | 0.06 | Why? |
| Anti-Bacterial Agents | 2 | 2021 | 10083 | 0.06 | Why? |
| Mexico | 2 | 2020 | 2787 | 0.06 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.06 | Why? |
| Social Isolation | 1 | 2021 | 5932 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| Anatomic Landmarks | 1 | 2020 | 44 | 0.05 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.05 | Why? |
| Edible Grain | 1 | 2019 | 26 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.05 | Why? |
| Neuroimaging | 2 | 2017 | 1106 | 0.05 | Why? |
| Heart Failure | 1 | 2021 | 6638 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Dietary Exposure | 1 | 2019 | 27 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.05 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.05 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2018 | 4775 | 0.05 | Why? |
| Radiography, Thoracic | 3 | 2020 | 5486 | 0.05 | Why? |
| Amniotic Fluid | 1 | 2020 | 249 | 0.05 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.05 | Why? |
| Rome | 1 | 2020 | 497 | 0.05 | Why? |
| Proportional Hazards Models | 2 | 2021 | 6543 | 0.05 | Why? |
| Food Contamination | 1 | 2019 | 142 | 0.04 | Why? |
| Evoked Potentials, Visual | 1 | 2017 | 40 | 0.04 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Phosphates | 1 | 2018 | 135 | 0.04 | Why? |
| Tuberculin Test | 1 | 2018 | 141 | 0.04 | Why? |
| Prognosis | 2 | 2019 | 32490 | 0.04 | Why? |
| Alkaline Phosphatase | 1 | 2018 | 257 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2021 | 10697 | 0.04 | Why? |
| Glasgow Coma Scale | 1 | 2017 | 249 | 0.04 | Why? |
| Neuropeptides | 1 | 2017 | 91 | 0.04 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.04 | Why? |
| Drug Resistance, Microbial | 1 | 2021 | 419 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| Patient Isolation | 2 | 2020 | 3182 | 0.04 | Why? |
| Fetal Blood | 1 | 2020 | 573 | 0.04 | Why? |
| Microtubule-Associated Proteins | 1 | 2017 | 187 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.04 | Why? |
| Inservice Training | 1 | 2020 | 477 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.04 | Why? |
| Creatinine | 1 | 2021 | 1443 | 0.04 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.03 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.03 | Why? |
| Ireland | 1 | 2020 | 1456 | 0.03 | Why? |
| Neurologic Examination | 1 | 2017 | 428 | 0.03 | Why? |
| Morbidity | 1 | 2020 | 1426 | 0.03 | Why? |
| Aged | 5 | 2022 | 215776 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
| Patient Admission | 2 | 2020 | 5250 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2021 | 1995 | 0.03 | Why? |
| Calcium | 1 | 2018 | 708 | 0.03 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.03 | Why? |
| Clinical Laboratory Techniques | 4 | 2020 | 23402 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2022 | 17020 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Intention | 1 | 2020 | 1380 | 0.03 | Why? |
| Steroids | 1 | 2017 | 904 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Image Processing, Computer-Assisted | 1 | 2020 | 1383 | 0.03 | Why? |
| Registries | 2 | 2021 | 12327 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Animals | 1 | 2020 | 78931 | 0.03 | Why? |
| Electroencephalography | 1 | 2017 | 1242 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2021 | 5440 | 0.03 | Why? |
| Mothers | 1 | 2020 | 1624 | 0.03 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.03 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2017 | 1153 | 0.02 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.02 | Why? |
| Placenta | 1 | 2020 | 1531 | 0.02 | Why? |
| Tomography, X-Ray Computed | 3 | 2021 | 25144 | 0.02 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.02 | Why? |
| Poverty | 1 | 2020 | 2302 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.02 | Why? |
| Germany | 1 | 2021 | 9196 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Biomarkers | 2 | 2019 | 23361 | 0.02 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.02 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Spain | 1 | 2021 | 15545 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |